New Data Shows Positive Potential for Osteoarthritis Treatment in Knees A new peer-reviewed paper published in a special issue of Stem Cells International evidences ...

The COVID-19 pandemic has focused attention upon global pharmaceutical industries, and will continue to do so for some time to come. However, despite the initial disr...

One of the main challenges of cell therapies is the maintenance and/or expansion of the required therapeutic phenotype in vitro. Moreover, to meet both the traceabili...

Growing demand for safe, effective medicines for pulmonary disorders and diseases has increased the research into their treatment. This is key to discovering how to e...

While 2020 was not the year anyone hoped it would be, it did succeed in showing us what medical research can achieve when the life sciences sector works together to o...

Effective drug discovery and development rely heavily on the availability of predictive pre-clinical models. For decades, target-based drug discovery has focused on i...

The current assessment of cell viability depends on endpoint measurements. Unfortunately, this ignores the levels and rates of in-between measurements. However, advan...

Completion of the first human genome sequence exactly 20 years ago opened up the tantalising prospect of a new era of precision treatments, with accurate genetic diag...

Finding ways to remove bottlenecks and improve yields in downstream processing for monoclonal antibodies (mAbs) continues to be a key focus area for biopharma manufac...

Therapeutics based on antibodies (Abs) are at the forefront of revolutionary treatments for cancer, autoimmunity and many other diseases. The application of high-thro...